FOXO Technologies Interim CFO Pens Shareholder Letter; Expects To Build Business Over Next 12-24 Months To Generate Revenues Of More Than $50M A Year
FOXO Technologies Interim CFO Pens Shareholder Letter; Expects To Build Business Over Next 12-24 Months To Generate Revenues Of More Than $50M A Year
FOXO科技臨時首席財務官撰寫股東信; 預計在接下來的12-24個月內發展業務,每年創造超過5000萬美元的收入
Dear Fellow Shareholders,
親愛的股東朋友們:
2024 has been an exciting, tumultuous and productive year for us. We believe the accomplishments already completed and that we believe will be achieved before year-end create a foundation from which we can build a successful enterprise that will increase shareholder value.
2024年對我們來說是令人興奮、動盪和富有成效的一年。我們相信已經取得的成就以及我們認爲會在年底之前取得的成就,爲我們構建一個成功企業打下了基礎,將增加股東價值。
The Company began 2024 with a continued focus on commercializing its epigenetic technology while, at the same time, exploring acquisition opportunities that would accelerate growth, revenue and synergies to expand our business in the health care and well-being sectors.
公司在2024年初繼續專注於商業化其表觀遺傳技術的同時,探索能加速增長、增加營業收入和協同效應的收購機會,以擴展我們在醫療保健和福祉領域的業務。
We started the last quarter of 2024 with two acquisitions of revenue generating businesses completed, that, without...
2024年最後一個季度,我們完成...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。